<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="nl">
	<id>https://informatiestandaarden.test-nictiz.nl/index.php?action=history&amp;feed=atom&amp;title=7phcy%3AV8.00_Toedieningsverzoek</id>
	<title>7phcy:V8.00 Toedieningsverzoek - Bewerkingsoverzicht</title>
	<link rel="self" type="application/atom+xml" href="https://informatiestandaarden.test-nictiz.nl/index.php?action=history&amp;feed=atom&amp;title=7phcy%3AV8.00_Toedieningsverzoek"/>
	<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=7phcy:V8.00_Toedieningsverzoek&amp;action=history"/>
	<updated>2026-04-06T06:53:37Z</updated>
	<subtitle>Bewerkingsoverzicht voor deze pagina op de wiki</subtitle>
	<generator>MediaWiki 1.43.0</generator>
	<entry>
		<id>https://informatiestandaarden.test-nictiz.nl/index.php?title=7phcy:V8.00_Toedieningsverzoek&amp;diff=34538&amp;oldid=prev</id>
		<title>Maarten Ligtvoet: Tekst vervangen - &quot;{{DISPLAYTITLE:.*}}&quot; door &quot;&quot;</title>
		<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=7phcy:V8.00_Toedieningsverzoek&amp;diff=34538&amp;oldid=prev"/>
		<updated>2020-08-26T12:27:32Z</updated>

		<summary type="html">&lt;p&gt;Tekst vervangen - &amp;quot;{{DISPLAYTITLE:.*}}&amp;quot; door &amp;quot;&amp;quot;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;nl&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Oudere versie&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Versie van 26 aug 2020 12:27&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Regel 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Regel 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;{{DISPLAYTITLE:Toedieningsverzoek|Toedieningsverzoek}}&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;noinclude&amp;gt;{{DocumentPart|ns=7phcy|title=V8.00_HL7v3-domeinspecificatie_Pharmacy}}&amp;lt;/noinclude&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;noinclude&amp;gt;{{DocumentPart|ns=7phcy|title=V8.00_HL7v3-domeinspecificatie_Pharmacy}}&amp;lt;/noinclude&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Maarten Ligtvoet</name></author>
	</entry>
	<entry>
		<id>https://informatiestandaarden.test-nictiz.nl/index.php?title=7phcy:V8.00_Toedieningsverzoek&amp;diff=30809&amp;oldid=prev</id>
		<title>Maarten Ligtvoet: Tekst vervangen - &quot;{{#customtitle:&quot; door &quot;{{DISPLAYTITLE:&quot;</title>
		<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=7phcy:V8.00_Toedieningsverzoek&amp;diff=30809&amp;oldid=prev"/>
		<updated>2020-07-20T01:35:41Z</updated>

		<summary type="html">&lt;p&gt;Tekst vervangen - &amp;quot;{{#customtitle:&amp;quot; door &amp;quot;{{DISPLAYTITLE:&amp;quot;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;nl&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Oudere versie&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Versie van 20 jul 2020 01:35&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Regel 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Regel 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;#customtitle&lt;/del&gt;:Toedieningsverzoek|Toedieningsverzoek}}&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;DISPLAYTITLE&lt;/ins&gt;:Toedieningsverzoek|Toedieningsverzoek}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;noinclude&amp;gt;{{DocumentPart|ns=7phcy|title=V8.00_HL7v3-domeinspecificatie_Pharmacy}}&amp;lt;/noinclude&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&amp;lt;noinclude&amp;gt;{{DocumentPart|ns=7phcy|title=V8.00_HL7v3-domeinspecificatie_Pharmacy}}&amp;lt;/noinclude&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Maarten Ligtvoet</name></author>
	</entry>
	<entry>
		<id>https://informatiestandaarden.test-nictiz.nl/index.php?title=7phcy:V8.00_Toedieningsverzoek&amp;diff=6311&amp;oldid=prev</id>
		<title>Kheitmann: Copy of V6.12</title>
		<link rel="alternate" type="text/html" href="https://informatiestandaarden.test-nictiz.nl/index.php?title=7phcy:V8.00_Toedieningsverzoek&amp;diff=6311&amp;oldid=prev"/>
		<updated>2014-01-13T11:19:32Z</updated>

		<summary type="html">&lt;p&gt;Copy of V6.12&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Nieuwe pagina&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{#customtitle:Toedieningsverzoek|Toedieningsverzoek}}&lt;br /&gt;
&lt;br /&gt;
&amp;lt;noinclude&amp;gt;{{DocumentPart|ns=7phcy|title=V8.00_HL7v3-domeinspecificatie_Pharmacy}}&amp;lt;/noinclude&amp;gt;&lt;br /&gt;
==Toedieningsverzoek==&lt;br /&gt;
{| cellspacing=&amp;quot;7&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
|&amp;#039;&amp;#039;&amp;#039;D-MIM:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;#039;&amp;#039;Pharmacy&amp;#039;&amp;#039;&lt;br /&gt;
|-&lt;br /&gt;
|&amp;#039;&amp;#039;&amp;#039;HL7v3 gestructureerde naam:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
|&amp;#039;&amp;#039;Medication Administration Request&amp;#039;&amp;#039;&lt;br /&gt;
|}&lt;br /&gt;
&amp;lt;br&amp;gt;&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Diagram&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
{|&lt;br /&gt;
|-&lt;br /&gt;
|[[Image: COCT_RM940000NL.png]]&lt;br /&gt;
|-&lt;br /&gt;
|Figuur 6 COCT_RM940000NL01 - R-MIM diagram&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Beschrijving&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
De CMET A_MedicationAdministrationRequestNL bevat de gegevenselementen die nodig zijn om de instructies voor het gebruik van de medicatie door te geven. Dit behelst met name doseerschema en doseerhoeveelheid, maar ook aanvullende gebruiksinstructies.&lt;br /&gt;
&lt;br /&gt;
De CMET heeft betrekking op een gebruiksafspraak met één bepaalde doseerhoeveelheid. Indien er sprake is van een medicatievoorschrift met wisselende doseerhoeveelheden, dan dient de CMET meerdere keren opgenomen te zijn (één keer per doseerhoeveelheid).&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Hierarchical Message Description&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
&lt;br /&gt;
{| cellspacing=&amp;quot;7&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
|&amp;lt;medicationAdministrationRequest&amp;gt;&lt;br /&gt;
|Toedieningsverzoek&lt;br /&gt;
|-&lt;br /&gt;
|[{		&amp;lt;support2&amp;gt;&amp;lt;medicationAdministrationInstruction&amp;gt; }]&lt;br /&gt;
|Gebruiksinstructie&lt;br /&gt;
|-&lt;br /&gt;
|[{ 	&amp;lt;precondition&amp;gt;&amp;lt;observationEventCriterion&amp;gt; }]&lt;br /&gt;
|Randvoorwaarde&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
De zogenaamde &amp;#039;&amp;#039;focal class&amp;#039;&amp;#039; van het R-MIM is dus de klasse &amp;#039;&amp;#039;&amp;#039;&amp;#039;&amp;#039;MedicationAdministrationRequest&amp;#039;&amp;#039;&amp;#039;&amp;#039;&amp;#039;, die betrekking heeft op één enkel ‘toedieningsverzoek’. Deze klasse fungeert als &amp;#039;&amp;#039;entry point&amp;#039;&amp;#039; voor de &amp;#039;&amp;#039;&amp;#039;&amp;#039;&amp;#039;CMET&amp;#039;&amp;#039;&amp;#039;&amp;#039;&amp;#039; in &amp;#039;&amp;#039;&amp;#039;&amp;#039;&amp;#039;message types&amp;#039;&amp;#039;&amp;#039;&amp;#039;&amp;#039; die &amp;#039;&amp;#039;COCT_MT940000NL&amp;#039;&amp;#039; gebruiken.&lt;/div&gt;</summary>
		<author><name>Kheitmann</name></author>
	</entry>
</feed>